Inhibition of antiviral drug cidofovir on proliferation of human papillomavirus‑infected cervical cancer cells

Yang,Jing; Dai,Lv‑Xia; Chen,Ming; Li,Bei; Ding,Nana; Li,Gang; Liu,Yan‑Qing; Li,Ming‑Yuan; Wang,Bao‑Ning; Shi,Xin‑Li; Tan,Hua‑Bing

doi:10.3892/etm.2016.3718

November-2016 Volume 12 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November-2016 Volume 12 Issue 5

Full Size Image

Article Open Access

Inhibition of antiviral drug cidofovir on proliferation of human papillomavirus‑infected cervical cancer cells

Authors:
- Jing Yang
- Lv‑Xia Dai
- Ming Chen
- Bei Li
- Nana Ding
- Gang Li
- Yan‑Qing Liu
- Ming‑Yuan Li
- Bao‑Ning Wang
- Xin‑Li Shi
- Hua‑Bing Tan
View Affiliations / Copyright

Affiliations: Department of Infectious Disease, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Experiment Teaching Center of Clinical Medicine, Chengdu College of Medicine, Chengdu, Sichuan 610500, P.R. China, Department of Microbiology, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Microbiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Pathobiology and Immunology, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China

Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 2965-2973
|
Published online on: September 20, 2016

https://doi.org/10.3892/etm.2016.3718
Expand metrics +

Abstract

In order to evaluate the potential application value of cidofovir (CDV) in the prevention of human papillomavirus (HPV) infection and treatment of cervical cancer, the inhibitory effect of CDV on the proliferation of HPV 18‑positive HeLa cells in cervical cancer was preliminarily investigated, using cisplatin (DDP) as a positive control. An MTT assay was used to analyze the effects of CDV and DDP on HeLa cell proliferation. In addition, clone formation assay and Giemsa staining were used to examine the extent of HeLa cell apoptosis caused by CDV and DDP. Flow cytometry was also used to detect the shape and size of apoptotic cells following propidium iodide staining, while western blot analysis identified the expression levels of of E6 and p53 proteins in HeLa cells. A cell climbing immunofluorescence technique was used to locate the subcellular position of p53 in HeLa cells. The results demonstrated that CDV and DDP inhibited the proliferation of HeLa cells in a concentration‑ and time‑dependent manner. Flow cytometry showed that CDV and DDP treatments resulted in cell arrest in the S‑phase, and triggered programmed cell death. Furthermore, western blot analysis revealed that CDV and DDP inhibited E6 protein expression and activated p53 expression in HeLa cells. Finally, the immunofluorescence results indicated that CDV and DDP inhibited the nuclear export of p53 by E6 protein, which is required for degradation of endogenous p53 by MDM2 and human papilloma virus E6. In conclusion, CDV and DDP inhibited HeLa cell proliferation in a concentration‑ and time‑dependent manner, reduced the expression of E6 protein, and reinstated p53 protein activity. Thus, CDV regulates cell cycle arrest and apoptosis, and may be a potential cervical cancer therapeutic strategy.

View Figures

View References

1	Drain PK, Holmes KK, Hughes JP and Koutsky LA: Determinants of cervical cancer rates in developing countries. Int J Cancer. 100:199–205. 2002. View Article : Google Scholar : PubMed/NCBI
2	Faridi R, Zahra A, Khan K and Idrees M: Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J. 8:2692011. View Article : Google Scholar : PubMed/NCBI
3	Ajay AK, Meena AS and Bhat MK: Human papillomavirus 18 E6 inhibits phosphorylation of p53 expressed in HeLa cells. Cell Biosci. 2:22012. View Article : Google Scholar : PubMed/NCBI
4	Shi JF, Canfell K, Lew JB and Qiao YL: The burden of cervical cancer in China: Synthesis of the evidence. Int J Cancer. 130:641–652. 2012. View Article : Google Scholar : PubMed/NCBI
5	Cox JT: Epidemiology and natural history of HPV. J Fam Pract Suppl. 3–9. 2006.
6	Tommasino M: The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 26:13–21. 2014. View Article : Google Scholar : PubMed/NCBI
7	Rosales R and Rosales C: Immune therapy for human papillomaviruses-related cancers. World J Clin Oncol. 5:1002–1019. 2014. View Article : Google Scholar : PubMed/NCBI
8	Collette DC and Zechel MA: Novel: treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir. J Oral Maxillofac Surg. 69:2383–2386. 2011. View Article : Google Scholar : PubMed/NCBI
9	Zhang YH, Peng HY, Xia GH, Wang MY and Han Y: Anticancer effect of two diterpenoid compounds isolated from Annona glabra Linn. Acta Pharmacol Sin. 25:937–942. 2004.PubMed/NCBI
10	Travé G and Zanier K: HPV-mediated inactivation of tumor suppressor p53. Cell Cycle. 15:2231–2232. 2016. View Article : Google Scholar : PubMed/NCBI
11	Kjær SK, Frederiksen K, Munk C and Iftner T: Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence. J Natl Cancer Inst. 102:1478–1488. 2010. View Article : Google Scholar : PubMed/NCBI
12	Koivusalo R, Krausz E, Ruotsalainen P, Helenius H and Hietanen S: Chemoradiation of cervical cancer cells: Targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. Cancer Res. 62:7364–7371. 2002.PubMed/NCBI
13	De Clercq E and Holý A: Acyclic nucleoside phosphonates: A key class of antiviral drugs. Nat Rev Drug Discov. 4:928–940. 2005. View Article : Google Scholar : PubMed/NCBI
14	Topalis D, Nogueira TC, De Schutter T, El Amri C, Krecmerova M, Naesens L, Balzarini J, Andrei G and Snoeck R: Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1. Oncotarget. 7:10386–10401. 2016.PubMed/NCBI
15	Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1129–1136. 1990. View Article : Google Scholar : PubMed/NCBI
16	Werness BA, Levine AJ and Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:76–79. 1990. View Article : Google Scholar : PubMed/NCBI
17	Jin Y, Wei Y, Xiong L, Yang Y and Wu JR: Differential regulation of survivin by p53 contributes to cell cycle dependent. Cell Research. 15:361–370. 2005. View Article : Google Scholar : PubMed/NCBI
18	Bargonetti J and Manfredi JJ: Multiple roles of the tumor suppressor p53. Curr Opin Oncol. 14:86–91. 2002. View Article : Google Scholar : PubMed/NCBI
19	Huang H, Huang SY, Chen TT, Chen JC, Chiou CL and Huang TM: Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells. J Cell Biochem. 91:756–765. 2004. View Article : Google Scholar : PubMed/NCBI
20	Donne AJ, Hampson L, He XT, Rothera MP, Homer JJ and Hampson IN: Cidofovir induces an increase in levels of low-risk and high-risk HPV E6. Head Neck. 31:893–901. 2009. View Article : Google Scholar : PubMed/NCBI
21	Abdulkarim B, Sabri S, Deutsch E, Chagraoui H, Maggiorella L, Thierry J, Eschwege F, Vainchenker W, Chouaïb S and Bourhis J: Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene. 21:2334–2346. 2002. View Article : Google Scholar : PubMed/NCBI
22	Stewart D, Ghosh A and Matlashewski G: Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. J Virol. 79:8773–8783. 2005. View Article : Google Scholar : PubMed/NCBI
23	Hillemanns P, Jentschke M, Evans TG, Soergel P and Hass R: Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women. Arch Gynecol Obstet. 289:1281–1286. 2014. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Inhibition of antiviral drug cidofovir on proliferation of human papillomavirus‑infected cervical cancer cells

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Related Articles